Learn More
PURPOSE Efficacy, safety, and cost implications are important considerations when choosing an ophthalmic treatment. Fixed-combination glaucoma medications containing brimonidine 0.2% and timolol 0.5%, or dorzolamide 2% and timolol 0.5%, were compared with brimonidine 0.2% and dorzolamide 2% that were used as adjunctive therapy to timolol 0.5%. METHODS A(More)
The opinions expressed herein are those of the publisher and do not necessarily reflect the views of the foundation. The methodology and the Discussion Guides were adapted by the RESPOND Project for use in Burkina Faso, Nigeria, Rwanda, and Togo, and for three program assessments conducted by EngenderHealth and the United Nations Population Fund (UNFPA) in(More)